Yubo International Biotech Limited
YBGJ
$0.0163
-$0.0097-37.31%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 80.02% | -15.45% | 44.01% | -9,319.05% | -43.62% |
| Total Depreciation and Amortization | -1.96% | -4.09% | -63.16% | 2.76% | 151.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.20% | 1.55% | -- | 86.29% | -60.02% |
| Change in Net Operating Assets | 161.65% | -5.25% | -296.09% | 40.49% | 47.97% |
| Cash from Operations | 108.67% | -18.57% | -67.03% | -1,915.69% | -179.54% |
| Capital Expenditure | -67.20% | 67.20% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -2.56% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23.13% | 79.33% | -- | -- | -- |
| Total Debt Issued | -16.80% | 32.16% | 38.47% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.18% | -9.86% | 48.77% | -- | -- |
| Foreign Exchange rate Adjustments | -129.70% | 19.50% | 4.56% | 722.00% | -208.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.35% | -94.48% | -190.91% | 200.00% | -77.20% |